(Reuters) - AbbVie Inc reported a 6.2 percent rise in quarterly net revenue, helped by demand for its flagship $15 billion-a-year arthritis treatment, Humira.
AbbVie revenue rises 6.2 percent
Read More
Bagikan Berita Ini
Langganan:
Posting Komentar (Atom)
0 Response to "AbbVie revenue rises 6.2 percent"
Posting Komentar